Positron announces the sale of Attrius PET scanner to Ochsner Health System of Louisiana

Positron Corporation (OTCBB:POSC) a molecular imaging solutions company focused on Nuclear Cardiology, announced the sale of its Attrius^TM PET scanner to Ochsner Health System of Louisiana.

“We selected Positron as our preferred vendor due to their dedication to high quality cardiology imaging and their vast amount of experience in this field.”

The Attrius™ is the only PET scanner on the market optimized for myocardial perfusion imaging with several specialized features making it the scanner of choice for nuclear cardiologist’s who value high quality PET imaging and cardiovascular specific interpretation tools.

Robert Bober, M.D., F.A.C.C, Director of Nuclear Cardiology at Ochsner states, “We are eager to offer Louisiana residents the best technology for coronary disease detection.” Dr. Bober went on to state, “We selected Positron as our preferred vendor due to their dedication to high quality cardiology imaging and their vast amount of experience in this field.”

Joseph Oliverio, Chief Technology Officer of Positron states, “The Attrius sale to Ochsner demonstrates our expanding market beyond private cardiology practices. We are grateful to have such a prestigious hospital network join our user group.” Oliverio further stated, “Positron has the ideal solution for thousands of cardiology groups and hospitals looking to improve their diagnostic accuracy at an affordable price. As a Company we have always been at the forefront of cardiac PET and see the market for our products and industry continue to expand at a rapid rate. As evidence we are experiencing an unprecedented demand for our new device.”